SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
65 hedge funds and large institutions have $218M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
65
Holding in Top 10
2
Calls
$247K
Puts
–
Top Buyers
| 1 | +$6.26M | |
| 2 | +$6.24M | |
| 3 | +$4.86M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.03M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.09M |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$1.34M | |
| 3 | -$789K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$525K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$509K |